Carlo Tanzi | Investor Relations |
Eric Shaff | President and Chief Executive Officer |
Matt Henn | Chief Scientific Officer |
Chris Shibutani | Cowen and Company |
Holly Barra | Goldman Sachs |
Chris Howerton | Jefferies |
Vernon Bernardino | H.C. Wainwright |
Ladies and gentlemen, thank you for standing by and welcome to Q3 2019 Seres Therapeutics Earnings Conference Call. At this time, all participants lines are in a listen-only mode. After the speaker’s presentation there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being recorded. [Operator Instructions]